Signature Estate & Investment Advisors LLC Acquires New Position in Entera Bio Ltd. (NASDAQ:ENTX)

Signature Estate & Investment Advisors LLC bought a new position in Entera Bio Ltd. (NASDAQ:ENTX) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 47,328 shares of the company’s stock, valued at approximately $90,000. Signature Estate & Investment Advisors LLC owned about 0.13% of Entera Bio as of its most recent SEC filing.

Separately, Virtu Financial LLC acquired a new position in shares of Entera Bio during the first quarter valued at $37,000. 14.11% of the stock is owned by institutional investors.

Entera Bio Trading Down 2.8 %

Shares of NASDAQ ENTX opened at $1.73 on Monday. Entera Bio Ltd. has a 12-month low of $0.52 and a 12-month high of $3.35. The company has a market cap of $61.91 million, a PE ratio of -6.65 and a beta of 1.58. The stock has a 50 day simple moving average of $1.85 and a 200-day simple moving average of $1.91.

Wall Street Analyst Weigh In

Separately, HC Wainwright reiterated a “buy” rating and issued a $10.00 price objective on shares of Entera Bio in a research report on Monday, November 11th.

About Entera Bio

Entera Bio Ltd., a clinical-stage company, focuses on the development and commercialization of orally delivered peptide and protein therapeutics for unmet medical needs. The company's product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials for the treatment of stress fractures.